Providing information to the drug discovery sector
LeadDiscovery was founded in 1998 by life scientists to expedite drug discovery and pharmaceutical development. Based on a solid background of experience from within the pharmaceutical research and development sector our aim is to help companies optimize drug discovery and product pipelines through the identification of breaking research and the in depth and expert evaluation of selected therapeutic areas.
At the same time we provide a showcase for pharmaceutical, biotechnology and academic organizations wishing to increase the exposure of their research to the drug development community.
We support the drug discovery and pharmaceutical development community through three key services: DailyUpdates, UpdatesPlus and PharmaReports
- DailyUpdates Launched in 2002 this popular e-mail alert service delivers information on breaking research, new clinical trials, drug development news and recently published market research and pipeline analysis reports. Today's headlines are below. Registration to receive the service is available here
- UpdatesPlus Developed in 2007 as an extension of DailyUpdates, UpdatesPlus provides a monthly in depth analysis of breaking research and development activity in high profile therapeutic areas. Further details can be found here
- PharmaReports We offer a wide range of in depth pharmaceutical reports. Our reports include market research reports and pipeline analyses. You can search our entire portfolio using LeadDiscovery's search engine. Alternatively as we are one of the few information providers that has extensive research and development experience we occupy a unique position of being able to source reports that accurately meet your needs. If we don't have a report that fits your requirements we can produce one through our pharmaceutical consultancy services.
Todays drug discovery and development headlines from across the DailyUpdates network
26th January 2012
Drug Development News: Sanofi Reports Positive Results for Once-daily Lyxumia® (lixisenatide) in Combination with Lantus® (insulin glargine) in Type 2 Diabetes
Headlined Journal Article: Neuroprotection of desferrioxamine in lipopolysaccharide-induced nigrostriatal dopamine neuron degeneration.
Clinical Trials: Trial of Vemurafenib With or Without Bevacizumab in Patients With Stage IV BRAFV600 Mutant Melanoma
Today’s Featured Pharmaceutical Report: RHEUMATOID ARTHRITIS: WORLD DRUG MARKET 2011-2021
Pharmaceutical Training Courses and Meetings: No current events.
LeadDiscovery recommends ClusterMed for faster discovery and automatic organization of PubMed results into categories
PharmaReports: LeadDiscovery offers in depth pharmaceutical reports on selected areas of the pharmaceutical and biotech sector. For a full list of our featured market research reports and pipeline analyses click here
Reports uploaded Jan 26th
- Atopic Dermatitis Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- Dyslipidemia Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- Autistic Disorder Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- Multiple Myeloma Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- Non-Hodgkin's Lymphoma (NHL) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Reports uploaded Jan 25th
- Biomarkers - technologies,markets and companies
- Cytogenetics - technologies,markets and companies
- Antiviral Therapeutics - technologies, markets and companies
- Biochips - technologies,markets and companies
Reports uploaded Jan 24th
- Drug Delivery in Cancer - technologies, markets and companies
- RNAi - technologies, markets and companies
- Gene Therapy - technologies, markets and companies
- Nanobiotechnologies- applications, markets and companies
- Drug Delivery in Central Nervous System Diseases - technologies,markets and companies
- Cardiovascular Drug Delivery - technologies,markets and companies
Reports uploaded Jan 23rd
- Animal Biotechnology - Technologies, Markets and Companies
- Pain Therapeutics - Drugs, Markets and Companies
- Personalized Medicine - scientific and commercial aspects
- Nitric Oxide - Therapeutics, Markets and Companies
- Alzheimer disease - new drugs, markets and companies
Reports uploaded Jan 18th
- Molecular Diagnostics - Technologies, Markets and Companies
- Proteomics - Technologies, Markets and Companies
- Neuroprotection - Drugs, Markets and Companies
- Transdermal Drug Delivery - Technologies, Markets, and Companies
- Cell Therapy - Technologies, Markets and Companies
Reports uploaded Jan 16th
Reports uploaded Jan 13th
- Clinical Trial Recruitment in Orphan Diseases - Patient Numbers in Ovarian Cancer Trials Exceed Other Orphan Diseases in Oncology
- Dental Device Market to 2017 - CAD/CAM and Minimal Invasive Cosmetic Dentistry to Drive the Market
- Drug Recalls and Warning Letters - Increasing Numbers Caused by Manufacturing Errors and Regulatory Non-compliance Issues
- Amyotrophic Lateral Sclerosis (ALS) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- Endometriosis Therapeutics- Pipeline Assessment and Market Forecasts to 2018
- Rheumatoid Arthritis Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- Chronic Kidney Disease (CKD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- Dysmenorrhea Therapeutics - Pipeline Assessment and Market Forecasts to 2018